New tuberculosis medicine may be on the way

Roughly one-third of the world's population is estimated to be infected with the bacteria causing tuberculosis. As KJZZ's Lynn Kelly reports, a research division of Johnson & Johnson is seeking U.S. approval for the first new type of medicine to fight deadly TB.

Syndicate content
Pledge Now
Give Monthly
Facebook logo
Twitter logo
Please read our Contributor Confidentiality Policy and the KJZZ Ethics and Practices guidelines. KJZZ supports Equal Employment Opportunities and works against discrimination in employment. For more information, please see KJZZ's Employment and EEO Information page.
For questions or comments about this website, please contact the KJZZ webmaster. For general comments or questions see the Contact KJZZ page for a listing of contacts by topic. Please note: Station policy mandates that listeners who win on-air giveaways on this station are not eligible to win again for 30 days.
Email regarding NPR's coverage, ethics, and funding can be sent to the NPR Ombudsman, who maintains an informative web page. For comments or concerns regarding NPR programs, listeners with a general inquiry may send an email to nprhelp@npr.org

KJZZ is a service of Rio Salado College, and Maricopa Community Colleges.
Copyright© 2013 KJZZ/Rio Salado College/MCCCD